Fusion Antibodies is a contract services organisation focused on therapeutic and diagnostic antibodies. It provides services to pharmaceutical and biotechnology customers across the drug discovery and early development process, including antibody discovery, sequencing, engineering and humanisation, and the supply of laboratory-grade material. Humanisation, which …
Faron is based in Turku, Finland, and is listed both on AIM in London and on Nasdaq First North Growth Market in Helsinki. It describes itself as a clinical-stage biopharmaceutical company focused on tackling cancer through novel immunotherapies. Its lead programme is bexmarilimab, an …
Feedback develops Bleepa, a clinical communications and medical imaging platform designed to help NHS clinicians share information and manage patient pathways outside traditional outpatient settings. Bleepa accounted for roughly 89% of sales in a recent reporting period. The company's strategy centres on community diagnostic …
EDX Medical develops and supplies digital diagnostic products and services aimed at the early detection and treatment of major diseases. Its offering includes biomarker testing panels, prostate cancer testing and an employee health screening service that combines blood tests with general health and family …
Headquartered in Cardiff, EKF Diagnostics develops, manufactures and sells diagnostic products. Its business is split into two divisions. Point-of-Care covers analysers and consumables for haemoglobin testing, including the DiaSpect and HemoPoint ranges, and diabetes testing. Life Sciences includes the company's beta-hydroxybutyrate (β-HB) reagent business, …
Cambridge Nutritional Sciences develops and manufactures in vitro diagnostic tests, with a focus on food intolerance and nutrition-related testing. Its products are designed to help practitioners and individuals identify foods that may be associated with adverse reactions, and are sold through laboratories, clinics, nutritional …
Cambridge Cognition develops digital tools for assessing cognitive function. Its best-known product, CANTAB, is a suite of computerised tests used in academic studies and by pharmaceutical companies running clinical trials in areas such as neurology and psychiatry. The company also provides electronic clinical outcome …
Coiled Therapeutics is a therapeutics-focused company quoted on AIM. Businesses in this field typically work on a technology platform or a pipeline of drug candidates aimed at specific diseases, advancing them through preclinical work and clinical trials before seeking regulatory approval or a partner …
CelLBxHealth operates in the life sciences field, where companies typically develop technologies and products aimed at clinical and laboratory users. When an AIM company changes its name, it is often signalling a new strategic direction, a refreshed brand for an existing product, or a …
Arecor develops therapeutics for diabetes, obesity and other cardiometabolic diseases. Its main focus is two insulin candidates: AT278, an ultra-concentrated, ultra-rapid-acting insulin at 500 units per millilitre, and AT290, at 200 units per millilitre. The company believes concentrated insulins could enable longer-wear, smaller and …